Philip R. Cohen, MD

Dr. Cohen is from the University of Houston Health Center, Texas; the Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston; and the Department of Dermatology, University of Texas Medical School, Houston.

Dr. Cohen reports no conflicts of interest in relation to this post.

The February 2012 issue of the New England Journal of Medicine (2012;366:707-714) featured an original article that presented the results of a multicenter phase 2 clinical trial of vemurafenib (N=132). More than 50% of patients with previously treated BRAF V600–mutant metastatic melanoma achieved vemurafenib-induced clinical responses. In addition, the investigators demonstrated that the median overall survival was approximately 16 months.

Henry W. Lim, MD

Dr. Lim is Chairman of the Department of Dermatology, Henry Ford Hospital, Detroit, Michigan. Dr. Lim also is the Immediate Past Chair of the American Academy of Dermatology’s Council on Science and Research.

Dr. Lim is a consultant for Clinuvel Pharmaceuticals, La Roche-Posay Laboratoire Pharmaceutique/L’Oréal, and Procter & Gamble, and an investigator for Clinuvel Pharmaceuticals and Estée Lauder.

On June 17, 2011, the US Food and Drug Administration (FDA) published the Final Rule on labeling and effectiveness testing of sunscreens (Fed Registr. 2011;76[117]:35620-35665). It is a major advancement for the regulation of sunscreens in the United States because for the first time the FDA specified the exact guidelines on the testing for UVA protection of sunscreens, and the labeling that is allowable on the package.

Philip R. Cohen, MD

Dr. Cohen is from the University of Houston Health Center, Texas; the Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston; and the Department of Dermatology, University of Texas Medical School, Houston.

Dr. Cohen reports no conflicts of interest in relation to this post.

Medical experimentation occurs daily and is essential to the development of new therapies. Medical experimentation also includes self-experimentation. Self-experimentation in dermatology is well-documented; indeed many investigators have subsequently published their own observations.